Literature DB >> 13292558

Clinical evaluation of azacyclonol, chlorpromazine, and reserpine on a group of chronic psychotic patients.

F RINALDI, L H RUDY, H E HIMWICH.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; PIPERIDINES/therapeutic use; PSYCHOSES/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh：

Substances：

Year:  1956        PMID： 13292558     DOI： 10.1176/ajp.112.9.678

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  6 in total

1.  Inadequacies in the reporting of clinical drug research.

Authors:  B S GLICK
Journal:  Psychiatr Q       Date:  1963-04

2.  Negative results with chlorpromazine and benactyzine in a group of chronic psychotics, with critical evaluation of similar studies.

Authors:  T A LOFTUS; D L CLARK; F R CROUSE; T E DILLON; D J JONES; H E LEFEVER
Journal:  Psychiatr Q       Date:  1961-01

3.  The role of chlorpromazine in the management of psychiatric patients.

Authors:  G F VAUGHAN
Journal:  Postgrad Med J       Date:  1957-11       Impact factor: 2.401

4.  Reserpine: Problems Associated with the Use of a So-called "Tranquillizing Agent".

Authors:  M Shepherd
Journal:  Proc R Soc Med       Date:  1956-10

5.  Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.

Authors:  M Fanciullacci; G Franchi; F Sicuteri
Journal:  Experientia       Date:  1974-12-15

6.  Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.

Authors:  A K Dixon
Journal:  Experientia       Date:  1968-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.